Biotechnology company Advanced Enzyme Technologies announced Q3FY26 results Revenue from operations on a consolidated basis increased to Rs 1,719 million in the Q3FY26 from Rs 1,691 million in the Q3FY25, a growth of 2%. Consolidated EBITDA during Q3FY26 stands at Rs 494 million as compared to Rs 553 million during Q3FY25, a decrease of 11%. Profit before tax stands at Rs 583 million during Q3FY26 as against Rs 530 million in Q3FY25, an increase of 10%. Profit after tax grew by 11% and stands at Rs 432 million during Q3FY26 as compared to Rs 389 million during Q3FY25. EBITDA margin stands at 29%, PBT margin stands at 34%, and PAT margin stands at 25% during the quarter. Financial costs stood at Rs 6 million during Q3FY26 as against Rs 9 million in Q3FY25. Depreciation and Amortization charge for the Q3FY26 stood at Rs 102 million as compared to Rs 90 million in Q3FY25. Earnings Per Share during Q3FY26 stand at Rs 3.80 as compared to Rs 3.36 in Q3FY25. Result PDF